haku: @freeterm value chains / yhteensä: 13
viite: 2 / 13
| Tekijä: | Hess, A.M. Rothaermel, F.T. |
| Otsikko: | When are assets complementary? Star scientists, strategic alliances, and innovation in the pharmaceutical industry |
| Lehti: | Strategic Management Journal
2011 : AUG, VOL. 32:8, p. 895-909 |
| Asiasana: | strategic management alliances innovation knowledge pharmaceutical industry companies scientists research |
| Vapaa asiasana: | value chains |
| Kieli: | eng |
| Tiivistelmä: | This study examines specific resource combinations (henceforth as: res-cmbs.) along the value chain, focusing on two mechanisms that are central to res-cmbs. for innovation in the pharmaceutical industry: 1) recruitment and retention of star scientists, and 2) engagement in strategic alliances. It is argued that res-cmbs. focusing on the same parts of the value chain are substitutes due to knowledge redundancies. In contrast, it is hypothesized that res-cmbs. linking different parts of the value chain are complements due to integration of non-redundant knowledge. In order to test the hypotheses, the innovative performance of more than 100 global pharmaceutical firms during three decades from 1974 to 2003 is empirically tracked. |
SCIMA